Comparison of the effects of three kinds of glucose‐lowering drugs on non‐alcoholic fatty liver disease in patients with type 2 diabetes: A randomized, open‐label, three‐arm, active control study

AIMS/INTRODUCTION: Non‐alcoholic fatty liver disease (NAFLD) is often observed in individuals with type 2 diabetes mellitus, and it is known that the presence of type 2 diabetes mellitus leads to the aggravation of NAFLD. The aim of this study was to compare the possible effects of three kinds of or...

Descripción completa

Detalles Bibliográficos
Autores principales: Kinoshita, Tomoe, Shimoda, Masashi, Nakashima, Koji, Fushimi, Yoshiro, Hirata, Yurie, Tanabe, Akihito, Tatsumi, Fuminori, Hirukawa, Hidenori, Sanada, Junpei, Kohara, Kenji, Irie, Shintaro, Kimura, Tomohiko, Nakamura, Yoshiko, Nishioka, Momoyo, Obata, Atsushi, Nakanishi, Shuhei, Mune, Tomoatsu, Kaku, Kohei, Kaneto, Hideaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610105/
https://www.ncbi.nlm.nih.gov/pubmed/32329963
http://dx.doi.org/10.1111/jdi.13279

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610105/
https://www.ncbi.nlm.nih.gov/pubmed/32329963
http://dx.doi.org/10.1111/jdi.13279

Ejemplares similares